Related Experiment Video

Updated: Apr 18, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K

Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease

Long Truong Hoang1, Chisato Shimizu2, Ling Ling1

  • 1Genome Institute of Singapore, Singapore City, Singapore.

Genome Medicine
|January 24, 2015
PubMed

Insights

Kawasaki disease (KD) involves innate immunity and cell migration pathways. The IL-1 signaling pathway is a key target for potential therapies in treating this childhood vasculitis.

Area of Science:

  • Immunology
  • Genomics
  • Pediatrics

Background:

  • Kawasaki disease (KD) is a critical childhood vasculitis with unknown etiology.
  • Coronary artery aneurysms occur in 25% of untreated KD patients, a unique characteristic.
  • Global gene expression profiling offers insights into disease pathophysiology.

Purpose of the Study:

  • Investigate molecular mechanisms in Kawasaki disease.
  • Identify key pathways and potential therapeutic targets in KD.
  • Compare KD transcriptional profiles with other pediatric infections and healthy controls.

Main Methods:

  • Analyzed whole blood transcriptional profiles of 146 KD subjects (acute and convalescent).
  • Compared KD profiles with pediatric bacterial/viral infections and healthy controls.
  • Examined transcript abundance related to treatment response and coronary artery outcomes.

Main Results:

  • Acute KD shows a strong innate immune system signaling pathway signature.
  • Cell motility pathways (paxillin, relaxin, actin, integrins, matrix metalloproteinases) are crucial in KD.
  • The IL-1β pathway was identified as a significant potential therapeutic target.

Conclusions:

  • The IL-1 signaling pathway is important in Kawasaki disease.
  • Innate immunity and cell migration are prominent in the acute phase of KD.
  • Gene expression profiling aids in understanding KD pathogenesis and identifying therapeutic strategies.
Abstract

More Related Videos

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.2K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

7.0K

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
98
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.3K
Gene Therapy00:59

Gene Therapy

4.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
72
Reporter Genes02:11

Reporter Genes

Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
13.9K